The 200B AI Networking Market Is Being Disrupted (3 Raises This Week Show How)
AI networking infrastructure market analysis
April 3, 2026
The Emerging Manager Playbook: How $250M Funds Are Built
The Emerging Manager Playbook: How $250M Funds Are Built
April 3, 2026
HGGC Fund V: The 12-Month Close That Changed Everything
HGGC Fund V: The 12-Month Close That Changed Everything
April 3, 2026
Multi-Strategy Fund Closes: Why Bain Built a $5B Conviction Model
Multi-Strategy Fund Closes: Why Bain Built a $5B Conviction Model
April 3, 2026
Angel Investor vs Venture Capitalist: Which Path Is Right for Your Startup?
Angel Investor vs Venture Capitalist: Which Path Is Right for Your Startup?
April 3, 2026
Standing Ovation's $34.2M Series B: Government Funds Beat VCs
Standing Ovation, a French precision fermentation company, closed a $34.2M Series B led by government-backed funds instead of traditional venture capital, signaling a structural shift in deep-tech biotech funding.
April 3, 2026
Ares Management's $5.4B Real Estate Fund Close Signals LP Rotation
Ares Management's $5.4B real estate fund close marks the largest PE-backed real estate vehicle in history, signaling LP capital rotation away from tech concentration toward alternative investments.
April 3, 2026
Retail Real Estate Fund Institutional Capital 2026: Nuveen's $330M Close
Nuveen's U.S. Cities Retail Fund closes at $330M with Australian superannuation funds, led by Rest's $250M commitment. Institutional capital bets on grocery-anchored retail resilience.
April 3, 2026
Series B Enterprise AI: Why Privacy Infrastructure Wins
Institutional investors are backing B2B privacy infrastructure over consumer AI chatbots. Alcatraz's $50M Series B shows why enterprise authentication solving compliance problems attracts serious capital.
April 3, 2026
EdTech: The $2.4B Valley & How Angels Are Winning in 2025
The 2024 EdTech funding crisis hit $2.4B—lowest in a decade. But 2025 is different. Here's where angels are actually finding winners.
April 3, 2026
Healthcare & Biotech: The $25.1B Market & Mega-Rounds in 2025
The US healthcare market is expanding to $5.15T in 2026. Biotech VC hit $25.1B in 2024. Here's where angels find the biggest exits.
April 3, 2026
The Top 20 Most Active Angel Groups in America — 2025 Rankings by Deals & Capital
Discover which angel groups closed the most deals and deployed the most capital in 2025. Rankings, investment metrics, and regional insights.
April 3, 2026